glp 1 arthritis Glucagon-like peptide-1 receptor agonists in arthritis: current insights and future directions Frontiers | Glucagon-like peptide-1 receptor

POINTER study a two-year, multisite clinical trial that found intensive, structured lifestyle intervention (focused on physical exercise, nutrition, cardiovascular health monitoring, cognitive challenge, and social engagement) improved cognitive function in older adults at risk for decline

Even two sessions per week provides meaningful muscle preservation benefits

Exhibit A: Creators on social media have started documenting what they believe is hair loss associated with GLP-1 use

doi: 10.1002/gps.1937 23 MansurRBZugmanAAhmedJChaDSSubramaniapillaiMLeeYet al

In addition, a selective GIP agonist showed very low effectiveness in reducing weight, while this co-agonist showed synergism in reducing fat mass in obese rodents